Credit Suisse analyst Christopher Parkinson raised his price target for Valspar (VAL) to $111 from $102, and says that following Sherwin-Williams' (SHW) Q4 results and public commentary regarding the company's acquisition, there appears to be a high likelihood that the deal closes at $113 per share. Additionally, the analyst notes that Sherwin-Williams indicated that a divestiture will be required to gain regulatory approval, but the asset in question "falls well below the $650M revenue threshold." He reiterates a Neutral rating on Valspar's shares.

BMO Capital lowered the firm's price target on Sherwin-Williams to $377 from $385 but keeps an Outperform rating on the shares. The company's Q1 results disappointed, as weather and customer project delays in the seasonally light Q1 more than offset early share gains tied to competitor issues, but its expected market share gains should amplify results in 2025/26 when housing improves with eventual interest rate cuts, the analyst tells investors in a research note.

Baird analyst Ghansham Panjabi raised the firm's price target on Sherwin-Williams to $310 from $300 and keeps a Neutral rating on the shares. The firm said in their opinion, current end-market weakness is a function of the lagged impact of previous increases in interest rates, noting that while raw material cost deflation was a partial offset, the recent up-tick in upstream input costs points toward a peak margin backdrop for Sherwin-Williams and peers.

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

Sees FY24 revenue growth up in low to mid-single digits, consensus $23.78B.

Consensus for Q2 revenue is $6.36B.